Unknown PHASE4 INTERVENTIONAL 2-arm NCT01399242

Efficacy of Certican® in Combination With Myfortic® in Renal (HUSJ1)

Efficacy and Safety of Certican® in Combination With Myfortic® in Adult Renal Allograft Recipients Following Calcineurin Inhibitor Withdrawal at Week 16 Compared to Patients Who Are Maintained on Tacrolimus and Myfortic®

Sponsor: Hospital Universitário São José

Conditions Disorder Related to Renal Transplantation

Interventions Certican

Updated 5 times since 2017 Last updated: Jul 20, 2011 Started: Aug 31, 2011 Primary completion: Jun 30, 2012 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Disorder Related to Renal Transplantation and is currently ongoing. Hospital Universitário São José leads this study, which shows 5 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitário São José

Data source: Hospital Universitário São José

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Belo Horizonte, Brazil